Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP1R21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LYN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBZF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED13L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRI3BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX6A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLCO5A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFYB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COQ3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PRKCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UHRF1BP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPD52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ILF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EVI2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on